These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11451336)

  • 1. Topical therapy with fluorinated and non-fluorinated corticosteroids in patients with atopic dermatitis.
    Gregurek-Novak T
    J Eur Acad Dermatol Venereol; 2001 Jan; 15(1):81-2. PubMed ID: 11451336
    [No Abstract]   [Full Text] [Related]  

  • 2. Once-daily 0.1% mometasone furoate cream versus twice-daily 0.1% betamethasone valerate cream in the treatment of a variety of dermatoses.
    Viglioglia P; Jones ML; Peets EA
    J Int Med Res; 1990; 18(6):460-7. PubMed ID: 2292327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open study of efficacy and safety of long-term treatment with mometasone furoate fatty cream in the treatment of adult patients with atopic dermatitis.
    Faergemann J; Christensen O; Sjövall P; Johnsson A; Hersle K; Nordin P; Edmar B; Svensson A
    J Eur Acad Dermatol Venereol; 2000 Sep; 14(5):393-6. PubMed ID: 11305382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of once-daily application of mometasone furoate 0.1% cream compared with twice-daily hydrocortisone valerate 0.2% cream in pediatric atopic dermatitis patients who failed to respond to hydrocortisone: mometasone furoate study group.
    Lebwohl M
    Int J Dermatol; 1999 Aug; 38(8):604-6. PubMed ID: 10487451
    [No Abstract]   [Full Text] [Related]  

  • 5. The effectiveness of wet wrap dressings using 0.1% mometasone furoate and 0.005% fluticasone proprionate ointments in the treatment of moderate to severe atopic dermatitis in children.
    Pei AY; Chan HH; Ho KM
    Pediatr Dermatol; 2001; 18(4):343-8. PubMed ID: 11576413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of mometasone furoate 0.1% cream and hydrocortisone 1.0% cream in the treatment of childhood atopic dermatitis.
    Vernon HJ; Lane AT; Weston W
    J Am Acad Dermatol; 1991 Apr; 24(4):603-7. PubMed ID: 2033138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited application of mometasone furoate on the face and intertriginous areas: analysis of safety and efficacy.
    Lebwohl M; Peets E; Chen V
    Int J Dermatol; 1993 Nov; 32(11):830-1. PubMed ID: 8270349
    [No Abstract]   [Full Text] [Related]  

  • 8. Once-a-day topical corticosteroids.
    Drug Ther Bull; 1995 Mar; 33(3):21-2. PubMed ID: 7587987
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the bioactivity of mometasone furoate 0.1% fatty cream, betamethasone dipropionate 0.05% cream and betamethasone valerate 0.1% cream in humans. Inhibition of UV-B-induced inflammation monitored by laser Doppler blood flowmetry.
    Bjerring P
    Skin Pharmacol; 1993; 6(3):187-92. PubMed ID: 8274288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical steroids under wet-wrap dressings in atopic dermatitis--a vehicle-controlled trial.
    Schnopp C; Holtmann C; Stock S; Remling R; Fölster-Holst R; Ring J; Abeck D
    Dermatology; 2002; 204(1):56-9. PubMed ID: 11834851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of effects of tacrolimus ointment and mometasone furoate cream on the epidermal barrier of patients with atopic dermatitis.
    Dähnhardt-Pfeiffer S; Dähnhardt D; Buchner M; Walter K; Proksch E; Fölster-Holst R
    J Dtsch Dermatol Ges; 2013 May; 11(5):437-43. PubMed ID: 23551950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing the formulation of semisolid preparations with special reference to corticosteroid products.
    Worthington HE
    Acta Derm Venereol Suppl (Stockh); 1973; 53():29-34. PubMed ID: 4518660
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of reservoir effect of topical corticosteroids in an experimental animal model by histamine-induced wheal suppression test.
    Abidi A; Ahmad F; Singh SK; Kumar A
    Indian J Pharmacol; 2012; 44(6):722-5. PubMed ID: 23248401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of atopic dermatitis after discontinuation of topical corticosteroid treatment.
    Fukaya M
    Arch Dermatol; 2000 May; 136(5):679-80. PubMed ID: 10815874
    [No Abstract]   [Full Text] [Related]  

  • 15. Animal studies with topical steroids.
    Weidmann H
    Acta Derm Venereol Suppl (Stockh); 1973; 53():25-7. PubMed ID: 4518659
    [No Abstract]   [Full Text] [Related]  

  • 16. Mometason furoate levels.
    Lipworth BJ
    Chest; 2001 Sep; 120(3):1034-5. PubMed ID: 11555548
    [No Abstract]   [Full Text] [Related]  

  • 17. Mometasone furoate versus betamethasone vale-rate in the treatment of allergic contact dermatitis.
    Grandolfo M; Vena GA; Angelini G; Bianchi B
    J Eur Acad Dermatol Venereol; 1999 Mar; 12(2):178-80. PubMed ID: 10343953
    [No Abstract]   [Full Text] [Related]  

  • 18. Systemic bioavailability of inhaled corticosteroids: appropriate and comparable methodology.
    Affrime MB; Banfield C; Nolop K
    Eur Respir J; 2001 Jul; 18(1):246. PubMed ID: 11510799
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppressive effects of topical mometasone furoate and tacrolimus on skin prick testing in children.
    Gradman J; Wolthers OD
    Pediatr Dermatol; 2008; 25(2):269-70. PubMed ID: 18429800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy and safety of loratadine syrup in childhood atopic dermatitis treated with mometasone furoate 0.1 per cent cream.
    Chunharas A; Wisuthsarewong W; Wananukul S; Viravan S
    J Med Assoc Thai; 2002 Apr; 85(4):482-7. PubMed ID: 12118496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.